Genoa's forward Giuseppe Rossi greets supporters before the Italian Serie A soccer match Genoa Cfc vs Benevento Calcio at Luigi Ferraris Stadium in Genoa, Italy. EPA/SIMONE ARVEDA
Rossi, who has played 30 times for the Azzurri in a career blighted by knee injuries, tested positive following an Italian league match between his team at the time, Genoa, and Benevento on May 12.
Dorzolamide is commonly found in eye drops. Its use is permitted if the athlete obtains a therapeutic use exemption, although if not applied to the eyes, it could be used as a diuretic.
The 31-year-old Rossi, formerly of Manchester United and Fiorentina but currently without a club, has denied using eye drops, according to the Gazzetta dello Sport daily.
Eyedrops containing “dorzolamide and brinzolamide, when administered topically in the eye, are not prohibited,” according to the World Anti-Doping Agency.
It added: “The rationale behind this exception is these drugs do not have a diuretic effect when topically applied.”
Rossi now faces a one-year ban by the Italian anti-doping agency (Nado), according to reports. Gazzetta said Rossi’s case is scheduled to be heard on October 1.
For more news your way, download The Citizen’s app for iOS and Android.
Download our app and read this and other great stories on the move. Available for Android and iOS.
